Bennet Y. Weber

Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo

Z. Giricz, P. Ferdinandy, Huimin Tian, 2022, Pharmaceuticals.